Insider Transactions in Q3 2022 at Inogen Inc (INGN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Jason Somer EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,145
-49.65%
|
$32,060
$28.16 P/Share
|
|
Sep 01
2022
|
Jason Somer EVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,306
+50.0%
|
-
|
|
Sep 01
2022
|
Bart Ben Sanford EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-3.34%
|
$8,904
$28.78 P/Share
|
|
Sep 01
2022
|
Bart Ben Sanford EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
508
+5.06%
|
-
|
|
Sep 01
2022
|
George J Parr Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-13.73%
|
$13,972
$28.78 P/Share
|
|
Sep 01
2022
|
George J Parr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,126
+23.66%
|
-
|
|
Sep 01
2022
|
Nabil Shabshab CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,828
-8.62%
|
$51,184
$28.78 P/Share
|
|
Sep 01
2022
|
Nabil Shabshab CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,685
+14.81%
|
-
|
|
Sep 01
2022
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
SELL
Open market or private sale
|
Direct |
1,576
-51.25%
|
$44,128
$28.16 P/Share
|
|
Sep 01
2022
|
Stanislav Glezer EVP, R&D & Chief Med. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,075
+50.0%
|
-
|